The present invention relates to the use of a compound of general Formula (1),
optionally in form of its tautomers, racemates, enantiomers, diastereomers and the mixtures thereof and optionally in form of the pharmacologically acceptable acid addition salts, solvates, hydrates, polymorphs, physiologically functional derivatives or prodrugs thereof, for the preparation of a pharmaceutical composition for the treatment of diseases characterized by abnormal cell proliferation in a human or non-human mammalian body by inhibition of polo like kinases as mitotic regulators.
本发明涉及通式(1)化合物的用途、
可选择以其同系物、外消旋体、对映体、非对映异构体及其混合物的形式,以及可选择以其药理学上可接受的酸加成盐、溶液剂、
水合物、多晶型物、生理功能衍
生物或原药的形式,用于制备药物组合物,通过抑制作为有丝分裂调节因子的polo样激酶,治疗以人或非人哺乳动物体内细胞异常增殖为特征的疾病。